Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 10Unknown 3Active not recruiting 3Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 58Squamous Cell Carcinoma of Head and Neck 37Nasopharyngeal Carcinoma 27Lung Neoplasms 25Uterine Cervical Neoplasms 22Biliary Tract Neoplasms 22Esophageal Squamous Cell Carcinoma 20Oropharyngeal Neoplasms 18Head and Neck Neoplasms 17Cholangiocarcinoma 17Urinary Bladder Neoplasms 14Neoplasms 14Neoplasm Metastasis 14Ovarian Neoplasms 13Esophageal Neoplasms 12Carcinoma 12Colorectal Neoplasms 11Stomach Neoplasms 10Small Cell Lung Carcinoma 10Carcinoma, Transitional Cell 8Mouth Neoplasms 7Laryngeal Neoplasms 7Hypopharyngeal Neoplasms 7Carcinoma, Squamous Cell 7Recurrence 6Nasopharyngeal Neoplasms 5Gallbladder Neoplasms 5Endometrial Neoplasms 5Breast Neoplasms 5Bile Duct Neoplasms 5

Interventions

Trastuzumab 3trastuzumab deruxtecan 2sacituzumab govitecan 2pertuzumab 2pembrolizumab 2Magnetic Resonance Spectroscopy 2Goserelin 2Carboplatin 2Biopsy 2Ado-Trastuzumab Emtansine 2zanidatamab 1trastuzumab biosimilar HLX02 1spartalizumab 1pyrotinib 1enfortumab vedotin 1camrelizumab 1bicalutamide 1apatinib 1abiraterone 1Tablets 1Specimen Handling 1Radiation 1Poly(ADP-ribose) Polymerase Inhibitors 1Platinum 1PF-05280014 1Ontruzant 1Ogivri 1Observation 1Maytansine 1Leuprolide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Salivary Gland Neoplasms × Cisplatin × Clear all
NCT04620187 2026-04-13

Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

Dana-Farber Cancer Institute

Phase 2 Recruiting
37 enrolled
Head & Neck

Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡